Evidence map›Paper›PMID 40657699›Full record

ArticleJournal of applied clinical medical physics2025

Enhancing inguinal tumor treatment outcomes with a customized 3D-printed bolus.

Xing Li, Stephen Bhagroo, Fan-Chi Su, Robabeh Rahimi, Jonathan Tward

Abstract readCase Reports
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xing LiDepartment of Advanced Radiation Oncology and Proton Therapy, Inova Schar Cancer Institute, Fairfax, Virginia, USA.ORCID https://orcid.org/0000-0003-4892-3210
Stephen BhagrooDepartment of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA.
Fan-Chi SuDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Robabeh RahimiDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-7651-5479
Jonathan TwardDepartment of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional boluses for pelvic lesions present challenges, including compromised skin dose coverage from large air gaps in treatment plans and increased uncertainties in treatment delivery due to variations in bolus fitting. This study evaluates the clinical benefits of a patient-specific, 3D-printed bolus (pBolus) in external beam radiation therapy (EBRT) for extramammary Paget's disease in the inguinal fold. A three-dimensional (3D) conformal plan utilizing the pBolus was compared to a conventional Superflab bolus (sBolus) under identical beam arrangements. The pBolus improved dose conformity by reducing air gaps in the treatment plan, and therefore, it was selected for clinical treatment. Weekly setup imaging revealed air gaps predominantly along the inguinal fold, demonstrating overall consistency in bolus fitting with minor air gap variations. Additionally, in vivo dosimetry confirmed dose accuracy. As a result, the patient achieved a favorable outcome, with no clinical evidence of disease at the follow-up visit.

Indexed as

Paget Disease, ExtramammaryPrinting, Three-DimensionalRadiotherapy Planning, Computer-AssistedHumansOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-Modulated3D‐Printingpatient‐specific treatment device

Identifiers

PMID40657699
PMCPMC12257348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.